Omid Farokhzad, M.D.

Omid Farokhzad, M.D.

Chief Executive OfficeratSeer· In proxies 2022–2024

Pay in FY2024-32% from the year before · Seer stock +19.1% the same year

Omid Farokhzad, M.D. was paid $3.5M in FY2024 (Dec), down 32%. Seer stock rose 19.1% that year.

Pay$100 in the stock at the end of FY21 → $10
Pay is from the Summary Compensation Table of each Seer proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. SeerPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -92%
  2. Senti BiosciencesPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?